
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 23 chart positions in 23 markets.
By chart position
- 🇬🇧GB · Life Sciences#6130K to 100K
- 🇨🇦CA · Life Sciences#1505K to 30K
- 🇮🇹IT · Life Sciences#3730K to 100K
- 🇯🇵JP · Life Sciences#6210K to 30K
- 🇪🇸ES · Life Sciences#9510K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
93K to 313K🎙 ~2x weekly·66 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
185K to 626K🇬🇧16%🇮🇹16%🇲🇾16%+20 more - Active Followers
Loyal subscribers who consistently listen
74K to 250K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Overcoming Barriers to Insulin Adherence
Jun 30, 2026
Unknown duration
Preventing & Managing Hypoglycemia
Jun 16, 2026
Unknown duration
Smart Tools & Technology for Better Insulin Outcomes
Jun 2, 2026
Unknown duration
Fixed-Ratio Combinations (FRCs) in Practice
May 19, 2026
Unknown duration
Safe & Effective Insulin Titration Strategies
May 5, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/30/26 | ![]() Overcoming Barriers to Insulin Adherence | In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients.They discuss:The barriers most misunderstood by cliniciansCommunication and motivational interviewing with patientsEmotional burden and fear of hypoglycemiaPractical strategies clinicians can use to support patients more effectivelyThe role of the wider diabetes healthcare teamDiana Isaacs is an Endocrine Clinical Pharmacist and Director of Education and Training in Diabetes Technology at the Cleveland Clinic.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 6/16/26 | ![]() Preventing & Managing Hypoglycemia | In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education.They discuss:Why hypoglycemia remains a major concern in insulin therapyKey risk factors to keep in mindClinical signs or patient-reported symptomsPrevention strategiesImportance of patient educationBalancing glycemic targets with hypoglycemia riskProf. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 6/2/26 | ![]() Smart Tools & Technology for Better Insulin Outcomes | In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support.They discuss:The new technologies making the biggest difference in insulin therapy todayThe role of smart pens, connected devices, and appsBiggest clinical impact - including adherence, titration and outcomesAccessibility of these tools in real-world practiceAdvisor role of AIThe promising future of technology in insulin therapy and a functional cureProfessor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 5/19/26 | ![]() Fixed-Ratio Combinations (FRCs) in Practice | In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations.They discuss:What exactly fixed-ratio combinations are and the problems they tackleIdentifying patient candidates and timelines for starting FRCsMeaningful benefits of FRCs compared with basal insulin aloneConcerns and limitations of FRCsHow guideline recommendations currently position FRCs in diabetes managementDr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 5/5/26 | ![]() Safe & Effective Insulin Titration Strategies | In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient.They discuss:The importance of titration in successful insulin therapyBarriers to titration, including patient self-managementHow clinicians can collaborate with patients in their titration journeyThe importance of language used by cliniciansPractical tips for simplifying titration in busy clinical settingsDr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 4/21/26 | ![]() Identifying Patients for Insulin Initiation in T2D | In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes.They discuss:When clinicians should consider insulin for patients with T2DAddressing concerns of weight gain with insulinADA/EASD recommendationsBarriers to insulin therapy and Type 2 diabetesAdvice on communication with patientsDr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 4/7/26 | ![]() Principles of Basal Insulin Therapy in Type 2 Diabetes | In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use.He is joined by Dr Giulio Romeo.They discuss:The role of basal insulin in normal physiology and why it matters in Type 2 diabetesGoals of basal insulin therapyWhat makes new basal insulins differentCurrent guidelines and recommendations for basal insulin therapyAlternatives to basal insulin therapyTips for safe and effective initiation and titrationDr Giulio Romeo is Associate Medical Director of the Adult Diabetes Section at Joslin Diabetes Center, and Assistant Professor of Medicine, Harvard Medical School.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 2/24/26 | ![]() Skin care management for people with diabetes using technology | In this episode of ATTD Tech Connect, host Julie Taplin and Dr Anna Korsgaard Berg discuss skin care management for people living with diabetes using diabetes technology.They discuss:The different skin layers and how they can be impacted by the use of diabetes technologyHow poor skin integrity directly affects glucose outcomesThings to look out for and ask as a clinicianSome practical prevention strategiesLatest research on using ultrasounds to measure skin depthDr Anna Korsgaard Berg is a Diabetes researcher at Steno Diabetes Center, Copenhagen and works in Pediatrics at Herlev Hospital.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 2/10/26 | ![]() How to reduce the burden and improve the quality of life for people living with Diabetes | In this episode of ATTD Tech Connect, host Julie Taplin and Professor Katarzyna Cyranka, clinical psychologist and psychotherapist, discuss the important topic of burden and quality of life related to diabetes and diabetes technologies for people living with diabetes.They discuss:Distinguishing diabetes distress from diabetes burnoutPossible sources of diabetes distressThe role of diabetes technology, especially AHCL, in reducing diabetes distressSigns to watch out for as clinicians, nurses, and educatorsTools to assist in naming and identifying sources of diabetes distressProfessor Katarzyna Cyranka is a clinical psychologist and certified psychotherapist, based in Krakow, Poland. This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 1/27/26 | ![]() Running a multi-disciplinary clinic & managing a Diabetes Team | In this episode of ATTD Tech Connect, host Julie Taplin and Professors Tadej Battelino and Klemen Dovč discuss the importance of multi-disciplinary diabetes care, and offer solutions to the common challenges that can crop up when managing a diabetes team.They discuss:Common challenges such as time constraints, busy clinics, and comorbiditiesSolutions such as effective communication, regular meetings, and the use of AI in automating workloadsImportance of synergy across various departments and professions within diabetes careProfessor Tadej Battelino is Co-Chair of ATTD and Chair of the International Diabetes Federation Europe. Professor Klemen Dovč is an Associate professor in the Faculty of Medicine at the University of Ljubljana.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/13/26 | ![]() Exercise management with the MiniMed™ 780G system | In this episode of ATTD Tech Connect, host Julie Taplin and Amy Jolley, Lead Diabetes Specialist Dietician, discuss exercise management in diabetes and the ways the MiniMed™ 780G system supports people with diabetes and healthcare professionals.They discuss:Barriers to exercise for people living with diabetesThe different glucose responses to aerobic and anaerobic exercise The features and benefits of AID systems compared with MDI therapy Advice on bolusing, fuelling during exercise, pre and post meal suggestions and ways to help reduce hyposAmy Jolley is a Lead Diabetes Specialist Dietician for the young adult and transition services at Salford Care Organisation, NHS, in the UK.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 12/16/25 | ![]() How the Smart MDI system provides visibility into insulin and its clinical impact | In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Ashley Mehnert, Diabetes Clinical Nurse Specialist, break down the Smart MDI system and its benefits.They discuss:What exactly is Smart MDI systemHow it differentiates from standard MDI therapyBenefits, including visibility to insulin useThe actionable alerts and clinical impactAshley Mehnert is a Diabetes Clinical Nurse Specialist working in the NHS in the north east of England.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 12/2/25 | ![]() Meal Management with the MiniMed™ 780G system | In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Maya Laron Hirsh, Clinical Dietician, discuss managing meals with the MiniMed™ 780G system.They discuss:Carb countingWhat to do if you miss a bolusHow to handle high fat and/or protein mealsMaya Laron Hirsh is a Clinical Dietician, Head of Diabetes & Obesity Nutrition Department at Sheba Medical Center, and Chair of the Diabetes Forum, Israeli Dietetic Association. She specializes in nutritional therapy for automated insulin delivery systems and has worked closely with people with diabetes using the 780G system.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 11/18/25 | ![]() Efficient Use of CareLink™ Clinic in Therapy Management | In this episode of ATTD Tech Connect, host Julie Taplin and her guests explore how healthcare professionals can make the most of CareLink™ Clinic - a powerful tool for supporting healthcare professionals and people living with Type 1 diabetes.They discuss:An overview of the CareLink™ Clinic reportsThe three-Step Methodology for Healthcare ProfessionalsUsing CareLink™ Clinic reports for Patient EducationDietary Insights and CareLink™ Clinic Douha Almajaly is a Diabetes Educator, and Maheen Ahmed is a Clinical Dietician, both from Sidra Medicine. Professor Goran Petrovski is the Medical Director for Medtronic Diabetes and an Endocrinologist & Diabetologist working at Sidra Medicine.This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.WePartner Online and Medtronic Diabetes AcademyMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 11/4/25 | ![]() The optimal Diabetes Technology educational pathway for Nurses & Educators | How can diabetes educators be supported in the fast-moving world of diabetes technology?In the first episode of ATTD Tech Connect, host Julie Taplin discusses the need for an educational pathway for diabetes educators when training PwD on the MiniMed™ 780G system with Geraldine Gallen.They discuss:Why the pathway is neededThe four key components of the pathwayThe barriers to providing diabetes educator trainingImplementing the pathway at King’s College HospitalGeraldine Gallen is a Type 1 Service Lead and Diabetes Nurse Consultant at Kings College Hospital, London. She is UK and Vice Chair of the Association of British Clinical Diabetologists (ABCD) – Diabetes Technology Network (DTN), UK. This series is sponsored by Medtronic Diabetes.Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.Minimed Medtronic Academy and WePartner OnlineMake sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 10/29/25 | ![]() Coming Soon: ATTD Tech Connect | Diabetes technology is evolving fast. In ATTD Tech Connect, we show how it can help healthcare professionals — nurses, educators, and dieticians — improve therapy and daily life for people living with diabetes.In this new series sponsored by Medtronic Diabetes, you’ll learn from diverse clinical experience and evidence-based guidance from leaders in diabetes care, tailored for those who support patients every day.Hosted by Julie Taplin, Dietician and Medtronic Diabetes Education Specialist, the series will explore practical strategies to reduce burden, support meal planning and exercise, and optimize outcomes in real-world care.Make sure you’re subscribed to the ATTD Podcast feed today. Explore further resources:ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Minimed Medtronic Academy and WePartner Online | — | ||||||
| 10/7/25 | ![]() The future of CGM in maternal health | In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek.They discuss:High-Risk Pregnancies and Current Gaps in CareChallenges in Type 2 Diabetes ResearchImpact of CGM Technology During PregnancyPre-Pregnancy and Pregnancy Care for Type 2 DiabetesThird Trimester and Delivery ConsiderationsEarly Adoption of Hybrid Closed LoopsDr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 9/30/25 | ![]() Postpartum CGM management and diabetes risk | In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event.She is joined by Dr Grenye O’Malley.They discuss:How glucose patterns and insulin needs change postpartumGDM as a spectrum to Type 2 diabetesCGM use for early detection of type 2 diabetes after GDMStrategies for transitioning from intensive pregnancy care to postpartum follow-upGrenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 9/23/25 | ![]() Common pitfalls and troubleshooting CGM use during pregnancy | In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.They discuss:Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatiguePractical troubleshooting strategies for clinicians and patientsThe role of education and support in overcoming CGM-related challengesSarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is the Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 9/16/25 | ![]() CGM research and trends in pregnancy | In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.They discuss:How CGM improves maternal and neonatal outcomesKey clinical trials including the CONCEPTT trialEvolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 9/9/25 | ![]() The Future of AI-Driven CGM in Diabetes & Metabolic Health | In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.They discuss:How AI and CGM technology is transforming diabetes and metabolic health managementAI identification of diabetes subtypes and personalised interventionsImpact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellnessPotential of AI-driven tools for early intervention and improved health outcomesDr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 9/2/25 | ![]() AI-Driven CGM & Personalized Medicine | In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.They cover:The Role of AI in Continuous Glucose MonitoringChallenges and Potential of AI in Diabetes ManagementAI and CGM for Young People with DiabetesPotential for AI to instigate behaviour changeDr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 8/26/25 | ![]() Common Questions Answered; Advancing Long-Acting Insulin in Practice | In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.They explore a wide range of topics including:General challenges in managing diabetesAdjusting insulin doses for better controlTime in tight range (TITR) and insulin managementFasting and diabetes managementImpact of GLP-1 on Type 1 diabetes managementChallenges of switching to weekly insulin injectionsDefining and managing hypoglycemia riskPersonalized diabetes management approachesDiabetes management in athletesDr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 8/19/25 | ![]() Real-World Applications and Success Stories | In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.They cover:Challenges and solutions in real-world insulin therapyHow personalized strategies improve patient outcomesLessons learned from patient-provider collaborationsFuture opportunities for enhancing patient engagement and adherenceHow to balance diabetes care with lifestyle choicesChristel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
| 8/12/25 | ![]() Updates and Emerging Trends in Long-Acting Insulin Therapy | In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.They cover:The latest clinical trials and guidelinesNew insulin formationsSmart delivery technologiesThe potential of GLP-1 and GIP hormonesAdvice on lowering treatment burden and improving the quality of life for those living with diabetesLucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.This is an accredited activity that gives you 1 CME/CPD credit.Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague. | — | ||||||
Showing 25 of 31
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
24 placements across 23 markets.
Chart Positions
24 placements across 23 markets.

























